$GRCE Income Statement | Understand Stock

$GRCE

$1.81 -$0.12 (6.22%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2026 12 months to Mar 31, 2026	FY2025 12 months to Mar 31, 2025	FY2024 12 months to Mar 31, 2024	FY2023 12 months to Mar 31, 2023	FY2022 12 months to Mar 31, 2022
Revenues from product sales
Operating expenses
Cost of sales of products
Research and development expenses
General and administrative expenses
Sales and marketing
Restructuring cost
Impairment of intangible assets
Impairment of Equipment
Impairment of Other assets and prepaid
Impairment of goodwill
Impairment of assets held for sale

Loss from operating activities
Foreign exchange loss
Change in fair value of derivative warrant liabilities
Interest and other income, net
Total other income, net
Loss before income tax benefit
Income tax benefit
Net loss
Basic and diluted loss per share (in dollars per share)
Weighted average number of shares outstanding (in shares)
Total comprehensive loss
Basic loss per share (in Dollars per share)
Diluted loss per share (in Dollars per share)
Weighted average number of shares outstanding, basic (in Shares)
Weighted average number of shares outstanding, diluted (in Shares)

Comments